Concept | Specific measurement variable | Patient- level analysis metric | Method of aggregation | Time point(s) |
---|---|---|---|---|
Primary outcome | ||||
 Quality of life | Functional Assessment of Cancer Therapy - Prostate Questionnaire | Change from baseline | Mean | 12 week |
Secondary outcomes | ||||
 Quality of life | Functional Assessment of Cancer Therapy - Prostate Questionnaire | Change from baseline | Mean | 6 month |
 Muscle mass | Whole-body lean body mass | Change from baseline | Mean | 6 month |
 Fat mass | Whole-body fat mass | Change from baseline | Mean | 6 month |
 Whole body bone strength | Whole-body bone mineral content | Change from baseline | Mean percent | 6 month |
Whole-body bone mineral density | Change from baseline | Mean percent | 6Â month | |
 Self-reported physical activity | International Physical Activity Questionnaire | Change from baseline | Mean | 12 week and 6 month |
 Functional well-being | Subscale from Functional Assessment of Cancer Therapy-Questionnaire | Change from baseline | Mean | 12 week and 6 month |
 Regional bone strength | Lumbar spine bone mineral density | Change from baseline | Mean percent | 6 month |
Femoral neck bone mineral density | Change from baseline | Mean percent | 6Â month | |
Total hip bone mineral density | Change from baseline | Mean percent | 6Â month | |
 Safety | Participants with any fracture | Number in each group | Proportion | 6 month |
Participants with falls that resulted in seeking medical assessment | Number in each group | Proportion | 6Â month | |
Exploratory outcomes | ||||
 Dyadic adjustment | DAS-7 | Change from baseline | Median | 12 week and 6 month |